Showing results (1-10 of 485) with videos related to
Sort By:
Pageof 49
Expert Opinion on Drug Safety|December 17, 2009
Clinical safety of ranibizumab in age-related macular degenerationUrsula Schmidt-ErfurthDie Ophthalmologie|May 1, 2024
[Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice]Ursula Schmidt-Erfurth, Sophie RiedlKlinische Monatsblatter Fur Augenheilkunde|September 16, 2024
Role of Artificial Intelligence in Retinal DiseasesJulia Mai, Ursula Schmidt-ErfurthJournal of Ophthalmology|July 17, 2010
Diabetic cataract-pathogenesis, epidemiology and treatmentAndreas Pollreisz, Ursula Schmidt-ErfurthInvestigative Ophthalmology & Visual Science|April 26, 2003
Sequence of early vascular events after photodynamic therapyStephan Michels, Ursula Schmidt-ErfurthOphthalmology|January 2, 2008
Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degenerationUrsula Schmidt-Erfurth, Stefan Sacu, Therapeutic Advances in Ophthalmology|March 28, 2022
Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapyGregor S Reiter, Ursula Schmidt-ErfurthAmerican Journal of Ophthalmology|March 28, 2006
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAlbert J Augustin, Ursula Schmidt-ErfurthEye (London, England)|March 19, 2024
The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3Bilal Haj Najeeb, Ursula Schmidt-ErfurthPageof 49